PT Pyridam Farma Tbk (PYFA.JK)
IDR 179.0
(1.13%)
IDR 179.0
(1.13%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.87 Billion IDR | -102.23% |
| 2022 | 345.85 Billion IDR | 566.45% |
| 2021 | 51.89 Billion IDR | 61.45% |
| 2020 | 32.14 Billion IDR | 110.35% |
| 2019 | 15.28 Billion IDR | 5.33% |
| 2018 | 14.5 Billion IDR | 20.28% |
| 2017 | 12.06 Billion IDR | 14.67% |
| 2016 | 10.51 Billion IDR | 3.79% |
| 2015 | 10.13 Billion IDR | -0.57% |
| 2014 | 10.19 Billion IDR | 19.93% |
| 2013 | 8.49 Billion IDR | -4.47% |
| 2012 | 8.89 Billion IDR | 27.03% |
| 2011 | 7 Billion IDR | 23.8% |
| 2010 | 5.65 Billion IDR | -17.15% |
| 2009 | 6.82 Billion IDR | 10.91% |
| 2008 | 6.15 Billion IDR | 48.0% |
| 2007 | 4.16 Billion IDR | 3.0% |
| 2006 | 4.03 Billion IDR | 44.62% |
| 2005 | 2.79 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -16.93 Billion IDR | 17.06% |
| 2024 Q3 | 11.28 Billion IDR | 166.65% |
| 2024 Q1 | -20.41 Billion IDR | 11.08% |
| 2023 Q4 | -22.95 Billion IDR | -275.91% |
| 2023 Q2 | -3.78 Billion IDR | -148.08% |
| 2023 Q3 | 13.05 Billion IDR | 445.21% |
| 2023 Q1 | 7.86 Billion IDR | -96.94% |
| 2023 FY | -7.7 Billion IDR | -102.23% |
| 2022 Q2 | 27.67 Billion IDR | 56.33% |
| 2022 Q4 | 256.84 Billion IDR | 548.99% |
| 2022 FY | 345.85 Billion IDR | 566.45% |
| 2022 Q1 | 17.7 Billion IDR | 499.84% |
| 2022 Q3 | -57.2 Billion IDR | -306.72% |
| 2021 Q4 | 2.95 Billion IDR | -81.58% |
| 2021 Q2 | 9.8 Billion IDR | -57.57% |
| 2021 Q1 | 23.11 Billion IDR | 131.84% |
| 2021 Q3 | 16.02 Billion IDR | 63.35% |
| 2021 FY | 51.89 Billion IDR | 61.45% |
| 2020 Q2 | 1.9 Billion IDR | -69.29% |
| 2020 FY | 32.14 Billion IDR | 110.35% |
| 2020 Q4 | 9.97 Billion IDR | -29.13% |
| 2020 Q3 | 14.06 Billion IDR | 638.82% |
| 2020 Q1 | 6.2 Billion IDR | -5.56% |
| 2019 Q1 | 3.22 Billion IDR | -50.18% |
| 2019 FY | 15.28 Billion IDR | 5.33% |
| 2019 Q4 | 6.56 Billion IDR | 34.53% |
| 2019 Q3 | 4.88 Billion IDR | 702.9% |
| 2019 Q2 | 607.94 Million IDR | -81.15% |
| 2018 FY | 14.5 Billion IDR | 20.28% |
| 2018 Q4 | 6.47 Billion IDR | 50.84% |
| 2018 Q3 | 4.29 Billion IDR | 363.29% |
| 2018 Q2 | 926.4 Million IDR | -67.1% |
| 2018 Q1 | 2.81 Billion IDR | -9.74% |
| 2017 Q2 | 646.42 Million IDR | -74.96% |
| 2017 Q1 | 2.58 Billion IDR | -37.81% |
| 2017 Q3 | 5.71 Billion IDR | 783.98% |
| 2017 FY | 12.06 Billion IDR | 14.67% |
| 2017 Q4 | 3.12 Billion IDR | -45.4% |
| 2016 Q3 | 1.09 Billion IDR | -64.11% |
| 2016 Q4 | 4.15 Billion IDR | 280.27% |
| 2016 FY | 10.51 Billion IDR | 3.79% |
| 2016 Q2 | 3.04 Billion IDR | 36.19% |
| 2016 Q1 | 2.23 Billion IDR | -75.41% |
| 2015 Q4 | 9.08 Billion IDR | 1222.05% |
| 2015 FY | 10.13 Billion IDR | -0.57% |
| 2015 Q2 | 260.05 Million IDR | -83.75% |
| 2015 Q1 | 1.59 Billion IDR | -82.52% |
| 2015 Q3 | -809.7 Million IDR | -411.37% |
| 2014 FY | 10.19 Billion IDR | 19.93% |
| 2014 Q1 | 2.27 Billion IDR | -43.44% |
| 2014 Q2 | -1.27 Billion IDR | -155.78% |
| 2014 Q4 | 9.15 Billion IDR | 25406.03% |
| 2014 Q3 | 35.87 Million IDR | 102.82% |
| 2013 Q4 | 4.02 Billion IDR | 83.06% |
| 2013 Q2 | -569.98 Million IDR | -120.05% |
| 2013 Q1 | 2.84 Billion IDR | -8.49% |
| 2013 FY | 8.49 Billion IDR | -4.47% |
| 2013 Q3 | 2.19 Billion IDR | 485.95% |
| 2012 Q1 | 3.83 Billion IDR | 1267.46% |
| 2012 FY | 8.89 Billion IDR | 27.03% |
| 2012 Q3 | 1.22 Billion IDR | 68.88% |
| 2012 Q4 | 3.1 Billion IDR | 152.68% |
| 2012 Q2 | 728.03 Million IDR | -81.01% |
| 2011 Q2 | 1.84 Billion IDR | -69.23% |
| 2011 Q4 | 280.35 Million IDR | 125.54% |
| 2011 Q1 | 5.98 Billion IDR | 0.0% |
| 2011 Q3 | -1.09 Billion IDR | -159.65% |
| 2011 FY | 7 Billion IDR | 23.8% |
| 2010 FY | 5.65 Billion IDR | -17.15% |
| 2009 FY | 6.82 Billion IDR | 10.91% |
| 2008 FY | 6.15 Billion IDR | 48.0% |
| 2007 FY | 4.16 Billion IDR | 3.0% |
| 2006 FY | 4.03 Billion IDR | 44.62% |
| 2005 FY | 2.79 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 190.05 Billion IDR | 99.011% |
| PT Merck Tbk | 199.72 Billion IDR | 99.059% |
| PT Phapros, Tbk | 71.32 Billion IDR | 97.365% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 1190.87 Billion IDR | 99.842% |
| PT Tempo Scan Pacific Tbk | 1257.95 Billion IDR | 99.851% |